Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Steris

Is STERIS Stock Underperforming the Nasdaq?

STERIS stock has significantly underperformed the Nasdaq over the past 52 weeks, yet analysts remain strongly bullish on the stock’s prospects.

Is STERIS Stock Underperforming the S&P 500?

Is STERIS Stock Underperforming the S&P 500?

STERIS has underperformed the S&P 500 over the past year, yet analysts remain moderately bullish about the stock’s potential.

3 Healthcare Innovators Transforming Patient Care

3 Healthcare Innovators Transforming Patient Care

The healthcare industry's long-term growth is fueled by rising R&D initiatives and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid medical device stocks Alcon (ALC), Becton, Dickinson and Company (BDX), and STERIS (STE) for potential returns. Keep reading.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

STERIS Stock Outlook: Is Wall Street Bullish or Bearish?

STERIS has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s potential.

Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2022

Please join “Business and Investment Opportunities in the Medical Sector in Thailand”

Thailand Board of Investment (BOI), Paris Office, cordially invites companies to join its webinar on Business and Investment Opportunities in the Medical Sector in Thailand with BOI Headquarters, Bangkok Dusit Medical Service (BDMS), Thai Food and Drug Administration (FDA), Sanet Asean Advisors, and STERIS (AST)

Ominous Death Cross Forms On Steris's Chart

If history is any guide, there may be trouble ahead for shares of Steris (NYSE:STE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

inkl

Read news from The Economist, FT, and more,
with one subscription

Steris: Q4 Earnings Insights

Steris: Q4 Earnings Insights

Steris (NYSE:STE) reported its Q4 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 0.99%, reporting an EPS of $2.04 versus an estimate of $2.02.

UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market

UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market

UnitedHealth and Vertex Pharmaceuticals are among five medical stocks with healthy action in a weak market.

Investors Business Daily

This Screen IDs Hot Stocks To Watch: Costamere, Ares, Steris Shine

This Screen IDs Hot Stocks To Watch: Costamere, Ares, Steris Shine

The Rising Profits Estimates screen reveals hot stocks to watch, such as Costamare, Ares Management and Steris.

Investors Business Daily

Steris Q3 Sales Jump 50% To $1.2B, Revises FY22 Guidance

Steris Q3 Sales Jump 50% To $1.2B, Revises FY22 Guidance

Steris plc (NYSE: STE)

Recap: Steris Q3 Earnings

Recap: Steris Q3 Earnings

Steris (NYSE:STE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 7.61%, reporting an EPS of $2.12 versus an estimate of $1.97.

1

Organisations

Vertex Pharmaceuticals

Apollo Global Management

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

243,785 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play